Heart Institute Research
The following documents and/or guidelines are intended for use by Heart Institute researchers and staff ONLY
Heart Institute Researchers/Staff Application Process:
Access to the application will be provided by accessing �myTOH' using your
Ottawa Hospital address (rather than Ottawa Heart address) and then clicking on
the IRIS icon. This is your customized
IRIS homepage. You will see the ability to apply to the REB.
All researchers/staff must access the new REB application through their own IRIS
homepage. You cannot share login information.
Should you have access problems to IRIS, please email
irissupport@ohri.zendesk.com for assistance.
- Submission Checklist (.doc, .pdf)
- Appendices
- Genetics Addendum (.doc, .pdf)
- Appendix A - Clinical Services
- Appendix B - Diagnostic Services
- Appendix C - Pharmacy
- Appendix H - Financial Disclosure
- The following appendices are the same for OHREB and HREB.
- Pathology and Laboratory Medicine Impact (.doc, .xls)
- Health Records (.doc, .pdf)
- Radiation Safety and Health Physics Impact
- Approval flow chart (.pdf)
- ADM XII 105 Research Projects w-Nuclear Substances or Radiation Emitting Devices Involving HUMANS (.doc, .pdf)
- Contact Persons Dosimetry Human Studies (.doc, .pdf)
- Human Studies Submission Cmtee Deadlines (.doc, .pdf)
- Radiation Dosimetry References Human Studies December (.doc, .pdf)
- Radiation Safety Form (.doc, .pdf )
- Department of Medical Imaging
- Research Summary for Department of Medical Imaging Service Requests (.pdf)
- Other forms
- The following appendices are the same for OHREB and HREB.
- Study Renewal
- Study Termination
To renew your study on an annual basis, you will need to complete and submit the following form 60 days in advance of the approval expiry date. If you have completed research participant enrollment, but research participants remain on follow-up, this form should be completed. If recruitment is still ongoing, submit a copy of the last approved Patient Information Sheet and/or Consent Forms. If they are being revised, attach a copy of the revised documents with all changes highlighted, and a clean final version of the revised document printed on original letterhead. Be sure to update the 'version' and 'date' on the revised form. Please ensure the HREB's contact phone number is correct. The number is 613-798-5555, extension 19865.
IT IS THE INVESTIGATOR’S RESPONSIBILITY TO ENSURE THAT STUDY APPROVAL DOES NOT LAPSE. PATIENT RECRUITMENT CANNOT CONTINUE IF STUDY APPROVAL LAPSESIf your study is complete, you need to inform us by submitting the following form. Please do not complete this form if patients remain on follow-up (see Annual Renewal Form).
- Study Amendments
- Adverse Event Reporting
If there has been an amendment to your study, please complete the following form. Be sure to include the appropriate revised documents. If there are changes required to the Patient Information and Consent Form because of the amendments, include a copy of the revised documents with all changes highlighted, and a clean final version of the revised document printed on original letterhead. Be sure to update the 'version' and 'date' on the revised form.
If there are any adverse events (SAEs) to report, please inform the HREB by using the following form. If there are changes required to the Patient Information and Consent Form because of these adverse events, include a copy of the revised documents with all changes highlighted, and a clean final version of the revised document printed on original letterhead. Be sure to update the 'version' and 'date' on the revised form.
- The following appendices are the same for OHREB and HREB.
French translation Request Form
HREB 2012 Website Schedule (.doc, .pdf)
HREB 2013 Website Schedule (.doc, .pdf)